Back
Schwab Fundamental U.S. Small CompanyETF Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
46
FNDA
Schwab Fundamental U.S. Small CompanyETF
Last Price:
58.92
Seasonality Move:
1.01%
Buy
70
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
59.44
Seasonality Move:
-10.21%
Sell
46
Schwab Fundamental U.S. Small CompanyETF (FNDA)
is a Sell
Is Schwab Fundamental U.S. Small CompanyETF a Buy, Sell or Hold?
- The current Schwab Fundamental U.S. Small CompanyETF [FNDA] share price is $57.33. The Score for FNDA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FNDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $59.45. The Score for CRBP is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FNDA Stock Price Chart
What is Schwab Fundamental U.S. Small CompanyETF's stock price today?
-
The Schwab Fundamental U.S. Small CompanyETF share price today is $57.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNDA is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $59.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
FNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 52.83 | Buy |
Chaikin Money Flow: | -144918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.67 - 58.95) | Buy |
Bollinger Bands (100): | (54.18 - 57.44) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.28 | Buy |
Relative Strength Index (14 RSI): | 56.7 | Buy |
Chaikin Money Flow: | -149487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.06 - 59.04) | Buy |
Bollinger Bands (100): | (39.61 - 54.55) | Buy |
FNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.97 | Buy |
20-day SMA: | 56.99 | Buy |
50-day SMA: | 56.38 | Buy |
200-day SMA: | 54.58 | Buy |
8-day EMA: | 57.05 | Buy |
20-day EMA: | 56.89 | Buy |
50-day EMA: | 56.57 | Buy |
200-day EMA: | 54.6 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.24 | Buy |
20-day SMA: | 55.87 | Buy |
50-day SMA: | 52.88 | Buy |
200-day SMA: | 32.21 | Buy |
8-day EMA: | 57.31 | Buy |
20-day EMA: | 55.86 | Buy |
50-day EMA: | 52.81 | Buy |
200-day EMA: | 36.82 | Buy |
Schwab Fundamental U.S. Small CompanyETF Earnings Growth & FNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.12 per share, an increase next quarter of $0.03 per share, an increase this year of $7.18 per share, and a decrease next year of $0.12 per share.
Schwab Fundamental U.S. Small CompanyETF Technical Analysis
Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |